Interindividual differences in aronia juice tolerability linked to gut microbiome and metabolome changes-secondary analysis of a randomized placebo-controlled parallel intervention trial

• Published in: Microbiome Vol. 12; no. 1; p. 49
• Main Authors: Lackner, Sonja, Mahnert, Alexander, Moissl-Eichinger, Christine, Madl, Tobias, Habisch, Hansjörg, Meier-Allard, Nathalie, Kumpitsch, Christina, Lahousen, Theresa, Kohlhammer-Dohr, Alexandra, Mörkl, Sabrina, Strobl, Herbert, Holasek, Sandra
• Format: Journal Article
• Language: English
• Published: England BioMed Central 09.03.2024; BMC
• Subjects: Acids; Aronia juice; Bile acid; Bile acids; Bioavailability; Chronic illnesses; Complaints; Digestive system; Female; Females; Flavonoids; Food; Gastrointestinal Microbiome - genetics; Gastrointestinal tract; Humans; Intervention; Intestinal microflora; Juices; Lipoproteins (very low density); Lipoproteins - metabolism; Low density lipoprotein; Metabolism; Metabolites; Metabolome; Metabolomics; Microbiomes; Microbiota; Mucus; Next-generation sequencing; Photinia - chemistry; Photinia - metabolism; Placebos; Polyphenols; Polyphenols - chemistry; Polyphenols - metabolism; Polysaccharides; Prebiotics; RNA, Ribosomal, 16S - genetics; RNA, Ribosomal, 16S - metabolism; rRNA 16S; Tolerability; Metabolomics; Gut microbiome modeling; Bile acid; Polyphenols; Aronia juice; Complaints; Mucus; Tolerability; Lipoprotein metabolism
• ISSN: 2049-2618; 2049-2618
• DOI: 10.1186/s40168-024-01774-4

Aronia melanocarpa is a berry rich in polyphenols known for health benefits. However, the bioavailability of polyphenols has been questioned, and the individual taste acceptance of the fruit with its specific flavor varies. We recently observed substantial differences in the tolerability of aronia juice among healthy females, with half of the individuals tolerating aronia juice without complaints. Given the importance of the gut microbiome in food digestion, we investigated in this secondary analysis of the randomized placebo-controlled parallel intervention study (ClinicalTrials.gov registration: NCT05432362) if aronia juice tolerability was associated with changes in intestinal microbiota and bacterial metabolites, seeking for potential mechanistic insights into the impact on aronia polyphenol tolerance and metabolic outcomes. Forty females were enrolled for this 6-week trial, receiving either 100 ml natural aronia juice (verum, V) twice daily or a polyphenol-free placebo (P) with a similar nutritional profile, followed by a 6-week washout. Within V, individuals were categorized into those who tolerated the juice well (Vt) or reported complaints (Vc). The gut microbiome diversity, as analyzed by 16S rRNA gene-based next-generation sequencing, remained unaltered in Vc but changed significantly in Vt. A MICOM-based flux balance analysis revealed pronounced differences in the 40 most predictive metabolites post-intervention. In Vc carbon-dioxide, ammonium and nine O-glycans were predicted due to a shift in microbial composition, while in Vt six bile acids were the most likely microbiota-derived metabolites. NMR metabolomics of plasma confirmed increased lipoprotein subclasses (LDL, VLDL) post-intervention, reverting after wash out. Stool samples maintained a stable metabolic profile. In linking aronia polyphenol tolerance to gut microbiota-derived metabolites, our study explores adaptive processes affecting lipoprotein profiles during high polyphenol ingestion in Vt and examines effects on mucosal gut health in response to intolerance to high polyphenol intake in Vc. Our results underpin the importance of individualized hormetic dosing for beneficial polyphenol effects, demonstrate dynamic gut microbiome responses to aronia juice, and emphasize personalized responses in polyphenol interventions.